SciGen Pte. Ltd.

SciGen Pte Ltd. is the global commercial arm of Yifan Pharmaceutical Co. Ltd, an integrated pharmaceutical company engaged in R&D, production and commercialization of API and finished dosage forms. SciGen has commercialized several biotech products, namely Gensulin®/Scilin®, Scitropin A™ and Zometa®. In addition to this, we will be commercialising new pipeline assets in diabetology and oncology. Our key focus therapy areas are in endocrinology, oncology, anti-infectives, immunology and hepatology. Who are we? - We believe in delivering solutions that matter to the people of today and innovating for the people of tomorrow. - To us, it is more than a business - it is a mission. What do we do? - We combine a specialty pharmaceutical business with a leading biologics biotechnology engine. - We partner to bring the best drugs we can find to the patients who need it most. How do we do it? - Our R&D efforts aim to deliver better patient outcomes through better science. - We understand that humility and service matter as it is not about us, it is about making patients’ lives better.